Vision AI for Pharmaceuticals

Bring Vision AI to every step of pharmaceutical manufacturing, from active pharmaceutical ingredient (API) and drug substance through formulation, fill-finish, packaging, and serialization. Built for the cGMP-regulated environments where one missed particulate, mis-aligned label, broken cleanroom protocol, or invalid audit trail can trigger an FDA 483, a regulatory hold, or a manufacturing campaign rejected at final batch review. Whether you're inspecting vials, ampoules, prefilled syringes, cartridges, IV bags, tablets, capsules, blister packs, lyophilized cakes, or sterile packaging, Roboflow extends your QC coverage to every unit on the line, on the cameras and inspection stations your facility already runs, validatable under FDA 21 CFR Part 11, EU GMP Annex 1 and Annex 11, GAMP 5, and DSCSA.

Visual Inspection Across Every Container and Dosage Form:

• Detect visible particulates per USP <790> in vials, prefilled syringes, ampoules, cartridges, and IV bags
• Verify fill volume, stopper and plunger seating, crimp seal integrity, and lyophilized cake structure
• Inspect tablets, capsules, blister packs, and bottles for damage, color, and labeling defects

Cleanroom, GMP Environment, and Process Monitoring:

• Verify aseptic gowning, PPE, and operator behavior in ISO 14644 cleanrooms and fill suites
• Catch line clearance gaps, changeover errors, and equipment cleanliness issues between batches
• Monitor controlled environments and document compliance for audit readiness

Serialization, Audit Trails, and Validation:

• Read and verify DSCSA serialization, 2D codes, lot numbers, and expiration dates
• Maintain immutable audit trails per FDA 21 CFR Part 11 and EU GMP Annex 11 for every container
• Deploy models validated under your existing CSV framework with IQ/OQ/PQ documentation

Bring intelligence to every step today. Stop visual quality risks from becoming 483s, recalls, batch rejections, or patient harm.

‍

Frequently asked questions

What is Vision AI for pharmaceuticals?

Vision AI for pharmaceuticals uses computer vision models to inspect drug products and processes across pharmaceutical manufacturing, from active pharmaceutical ingredient (API) and drug substance through formulation, fill-finish, packaging, and distribution. The system extends QC coverage to every unit on the line, catching visible particulates in injectables, fill volume errors, stopper and crimp seal defects, tablet and capsule damage, lyophilized cake anomalies, label and serialization issues, cleanroom and gowning compliance gaps, and audit trail breaks. Pharma manufacturers use it to cut scrap, prevent 483 observations, reduce false rejects on AVI lines, and document compliance under FDA 21 CFR Part 11, 21 CFR Part 211 (cGMP), EU GMP Annex 1 and Annex 11, DSCSA, USP <790>, and GAMP 5.

Can Vision AI inspect visible particulates per USP <790> at fill-finish line speed?

Yes. USP <790> visible particulate inspection is the canonical pharmaceutical AVI task, and exactly where Roboflow's deep-learning approach extends what traditional rule-based AVI catches. A single missed visible particle in a vial of biologic, sterile injectable, or large-volume parenteral can trigger an FDA recall and a warning letter that affects every batch released since the last successful audit. Roboflow models can be trained against your specific USP <790> visible particulates acceptance criteria and the USP <1790> visual inspection guidance, including detection of glass fragments, fibers, stopper material, protein aggregates, and foreign matter at the sensitivity levels your QA team requires. The system runs at the line speeds modern fill-finish lines operate at, with edge-optimized models that flag suspect containers for trained inspector adjudication and reduce false rejects from air bubbles, stopper coatings, and benign artifacts that rule-based systems often struggle with.

Does Vision AI for pharmaceuticals support 21 CFR Part 11, EU GMP, and DSCSA?

Yes. Roboflow models can be trained against your specific FDA 21 CFR Part 11 (Electronic Records and Electronic Signatures), 21 CFR Part 211 (cGMP for Finished Pharmaceuticals), EU GMP Annex 1 (Manufacture of Sterile Products), EU GMP Annex 11 (Computerized Systems), DSCSA (Drug Supply Chain Security Act serialization requirements), USP <790> (Visible Particulates in Injections), USP <1790> (Visual Inspection guidance), ICH Q7/Q9/Q10, PIC/S, and WHO GMP requirements. The system produces a validated inspection record for every container that supports your FDA, EMA, MHRA, PMDA, and other regulatory submissions, batch release documentation, and audit response packets. Your quality and regulatory teams own the acceptance criteria; Roboflow provides the inspection engine that enforces them at line speed, with audit trails for training data, model versions, and inspection results that pass scrutiny under FDA 21 CFR Part 11 and EU GMP Annex 11.

Can it integrate with our existing AVI line, MES, eQMS, and validation workflow?

Yes. Roboflow Inference exposes a standard API and supports common pharma manufacturing protocols, so Vision AI inspection events flow into your existing AVI line equipment, MES, eQMS, EBR, and validation workflow. Roboflow can deploy alongside existing AVI lines from Seidenader (Korber), Bosch / Syntegon, Brevetti CEA, Antares Vision, and Stevanato Group, adding a deep-learning layer to the rule-based vision systems already in production, or run as the primary inspection on new lines. Customers integrate with MasterControl, Veeva Vault QMS, Sparta TrackWise, Werum PAS-X (EBR and MES), SAP, and custom GMP platforms through REST, MQTT, OPC UA, and direct database writes. Models are designed to be validatable under FDA 21 CFR Part 11 with IQ/OQ/PQ-ready documentation, audit trails for training data, model versions, and inspection results that pass validation engineer review and FDA audit scrutiny. Hardware fits ISO 14644 cleanroom environments.

‍

‍